Manufacturer perspectives on maximizing success for orphan drug commercialization
You’re a manufacturer of orphan drugs, which means the new product you’ve spent years developing has an established patient population that’s desperate to receive it the moment it’s first available.
How do you ensure a successful launch … one where patient financial hurdles are swiftly overcome, supply chain and order management works smoothly and product arrives safely to global locations?
To address all those questions, we’ll take a look at the brief story of Manufacturer M, which met each challenge head-on … and saw success demonstrated directly in the life of a patient.
See what it takes at ittakesamerisourcebergen.com
Interested in learning more about the Orphan Drug industry? Attend the Global Orphan Drug Congress USA 2017 on April 19-21, 2017 at the Washington Marriott Wardman Park, Washington, D.C. Register now >>
**eBook is provided by AmerisourceBergen